Brief report: Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2648-2651

  Auchus, Richard J ^a   Chandler, Donald W ^c   Singeetham, Sarita ^a   Chokshi, Neema ^a   Nwariaku, Fiemu E ^a   Dolmatch, Bart L ^a   Holt, Shelby A ^a   Wians Jr , Frank H ^a   Josephs, Shellie C ^a   Trimmer, Clayton K ^a   Lopera, Jorge ^a   Vongpatanasin, Wanpen ^a   Nesbitt, Shawna D ^a   Leonard, David ^b   Victor, Ronald G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Esoterix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXYCORTICOSTERONE; HYDROCORTISONE; BIOLOGICAL MARKER;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; STEROID ANALYSIS; STEROIDOGENESIS; VENOUS BLOOD; BLOOD; HYPERALDOSTERONISM; METABOLISM; PILOT STUDY; REPRODUCIBILITY; RETROSPECTIVE STUDY; VASCULARIZATION; VEIN;

18-HYDROXYCORTICOSTERONE; ADRENAL GLANDS; BIOLOGICAL MARKERS; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; VEINS;

EID: 34447130276     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2631     Document Type: Article

References (20)

1. Auchus RJ 2003 Aldo is back: recent advances and unresolved controversies in hyperaldosteronism. Curr Opin Nephrol Hypertens 12:153-158
2. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050.
3. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F, PAPY Study Participants 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232-238
4. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C 2006 Long-term renal outcomes in patients with primary aldosteronism. JAMA 295:2638-2645
5. Rossi GP, Di Bello V, Ganzaroli C, Sacchetto A, Cesari M, Bertini A, Giorgi D, Scognamiglio R, Mariani M, Pessina AC 2002 Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 40:23-27
6. Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Heerden JA 2001 Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135:258-261
7. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P 2002 Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892-896
8. Lim PO, Jung RT, MacDonald TM 1999 Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol 48:756-760
9. Irony I, Kater CE, Biglieri EG, Shackleton CH 1990 Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens 3:576-582
10. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW 2001 Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066-1071
11. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA 2004 Role for adrenal venous sampling in primary aldosteronism. Surgery 136:1227-1235
12. Nwariaku FE, Miller BS, Auchus RJ, Holt S, Watumull L, Dolmatch B, Nesbitt S, Vongpatanasin W, Victor R, Wians Jr FH, Livingston E, Snyder III WH 2006 Primary hyperaldosteronism: advantages of adrenal vein sampling for subtype differentiation. Arch Surg 141:497-503
13. Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill Jr JR 2000 Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85:4526-4533
14. Biglieri EG, Schambelan M 1979 The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 49:87-91
15. Kem DC, Tang K, Hanson CS, Brown RD, Painton R, Weinberger MH, Hollifield JW 1985 The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. J Clin Endocrinol Metab 60:67-73
16. Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N 1985 The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. J Clin Endocrinol Metab 60:225-228
17. Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, Mantero F, Pessina AC 2006 Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 24:371-379
18. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L 1998 Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 83:3996-4001
19. Kater CE, Biglieri EG 1982 Zona fasciculata origin of 18-hydroxycorticosterone in the chronically suppressed zona glomerulosa. J Clin Endocrinol Metab 55:628-633
20. Rao A, Melby JC, Wilson TE 1995 Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism. J Clin Endocrinol Metab 80:1677-1680